The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,314.00
Bid: 12,312.00
Ask: 12,314.00
Change: 196.00 (1.62%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,330.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

Mon, 17th May 2021 18:00

(Adds China's comments, vaccine export)

By Steve Holland

WASHINGTON, May 17 (Reuters) - President Joe Biden will send
at least 20 million more COVID-19 vaccine doses abroad by the
end of June, marking the first time the United States is sharing
vaccines authorized for domestic use.

The move marks a notable pivot from the White House as the
administration seeks to use the country's vaccine supply as a
diplomatic tool with the pandemic outlook brightening at home.

Biden announced on Monday that his administration will send
doses of the Pfizer Inc/BioNTech SE, Moderna
Inc and Johnson & Johnson vaccines, on top of
60 million AstraZeneca Plc doses he had already planned
to give to other countries.

Unlike the others, AstraZeneca's shot is not yet authorized
for use in the United States.

"Just as in World War Two America was the arsenal of
democracy, in the battle against COVID-19 pandemic our nation is
going to be the arsenal of vaccines," Biden said.

The president has been under pressure to share vaccines to
help contain worsening epidemics from India to Brazil, where
health experts fear new, more contagious coronavirus variants
could undermine the effectiveness of available shots.

Biden noted that no other country will send more vaccines
abroad than the United States. So far, the United Stages has
sent a few million AstraZeneca doses to Canada and Mexico.

"We want to lead the world with our values with this
demonstration of our innovation, ingenuity, and the fundamental
decency of American people," Biden said.

China, which has exported hundreds of millions of doses
mainly to developing countries and pledged to donate at least
nearly 4 million doses, said it welcomed the U.S. move but it
would not use vaccines as a tool in diplomatic relations.

"We welcome if the U.S. can implement its commitment to
vaccine assistance at an early date and provide tangible help to
developing countries in their fight against the epidemic," Zhao
Lijian, a spokesman at China's foreign ministry, said.

"Unlike the United States, China will not use vaccine
influence to lead the world and will not chant empty slogans
without action," he said at a regular briefing on Tuesday.

The White House has not provided any details about what
countries will receive the shots. Biden said that Jeff Zients,
who heads the U.S. vaccine efforts, will now also lead the
global vaccine push.

The United States has administered more than 272 million
COVID-19 vaccine doses and distributed more than 340 million,
according to federal data updated on Monday morning.

With more and more Americans vaccinated, U.S. deaths from
COVID-19 last week fell to their lowest in nearly 14 months,
while the number of new cases declined for a fifth consecutive
week, according to a Reuters analysis of state and county data.

Biden warned that those who do not get vaccinated "will end
up paying the price" as he lamented that "we're still losing too
many Americans" despite the significant progress.

(Reporting By Steve Holland, Carl O'Donnell and Jarrett
Renshaw; Additional reporting by Beijing Newsroom; Writing by
Jarrett Renshaw; Editing by Trevor Hunnicutt, Bill Berkrot and
Andrew Heavens)

More News
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.